BioAtla BCAB
OTC BCAB
$1.80 -0.01 (-0.55%)
At close: Nov 10, 2026 · 4:00 PM EST

BioAtla (BCAB) Non Operating Interest Expenses (2020 - 2021)

Updated

BioAtla's Non Operating Interest Expenses was $3,000 in FY2021, down 99.8% from $1.39 million in FY2020.

Analysis

BioAtla (BCAB) Non Operating Interest Expenses (2020 - 2021) Analysis & Trends

  • Per Business Quant data, Non Operating Interest Expenses in earlier years was $1.39 million in FY2020 (-14.8%) and $1.63 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 BioAtla 2.99 Mn -15.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 1,000.00
Mar 31, 2021 2,000.00
Dec 31, 2020 2,000.00
Sep 30, 2020 86,000.00
Jun 30, 2020 754,000.00
Mar 31, 2020 547,000.00
API Access

BioAtla Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BCAB&period=max&api_key=YOUR_API_KEY